Medicina de Familia-SEMERGEN最新文献

{"title":"Long COVID-19 and primary care: Challenges, management and recommendations","authors":"E. Ahmad ,&nbsp;S. Ahmed ,&nbsp;B. Ahmad ,&nbsp;M.H. Arif ,&nbsp;H.M.A. Ilyas ,&nbsp;N. Hashmi ,&nbsp;S. Ahmad","doi":"10.1016/j.semerg.2023.102188","DOIUrl":"10.1016/j.semerg.2023.102188","url":null,"abstract":"<div><p>Long COVID-19, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), is characterized by persistent symptoms after COVID-19 onset. This article explores the challenges, management strategies, and recommendations for addressing long COVID-19 in primary care settings. The epidemiology of long COVID-19 reveals significant variability, with a substantial portion of COVID-19 survivors experiencing post-acute symptoms. Pathophysiological mechanisms include viral persistence, endothelial dysfunction, autoimmunity, neurological dysregulation, and gastrointestinal dysbiosis. Multiple risk factors, including age, sex, pre-existing comorbidities, smoking, BMI, and acute COVID-19 severity, influence the development of long COVID-19. Effective management requires proactive measures such as vaccination, identification of high-risk populations, public awareness, and post-infection vaccination. Collaboration of primary care physicians with specialists is essential for holistic and individualized patient care. This article underscores the role of primary care physicians in diagnosing, managing, and mitigating the long-term effects of COVID-19.</p></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139673601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Choque entre la regulación española del aborto y la sentencia estadounidense Dobbs contra Jackson","authors":"M.A. Lasheras-Pérez","doi":"10.1016/j.semerg.2023.102174","DOIUrl":"10.1016/j.semerg.2023.102174","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139673603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impacto de la pandemia de COVID-19 en las tendencias de mortalidad por enfermedades cardiovasculares en México, 2000-2022","authors":"O.S. Medina-Gómez","doi":"10.1016/j.semerg.2023.102170","DOIUrl":"10.1016/j.semerg.2023.102170","url":null,"abstract":"<div><h3>Objective</h3><p>To estimate the impact of the COVID-19 pandemic on cardiovascular disease (CVD) mortality trends in Mexico.</p></div><div><h3>Methods</h3><p>An ecological study was conducted where deaths from CVD reported in Mexico under the ICD-10 classification with codes I10 to I99 for the period 2000–2022 were analyzed. Age-standardized mortality rates were calculated at the national and state levels, then the annual percentage variation was estimated using joinpoint analysis to know the changes in the mortality trend in the period studied.</p></div><div><h3>Results</h3><p>There was an increase of 27.96 deaths per 100,000 inhabitants from 2000 to 2022 in Mexico. The joinpoint analysis shows in the period 2019–2021 an annual percentage change at the national level of 17,398 and subsequently a negative trend is presented between the years 2021–2022. The states of Guanajuato, Tlaxcala and Querétaro showed the largest increases in CVD mortality trends during the COVID-19 pandemic.</p></div><div><h3>Conclusions</h3><p>The trend in CVD mortality in Mexico increased significantly during the COVID-19 pandemic.</p></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139673600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hemorragia alveolar difusa inducida por inhalación de vapor de aceite vegetal: a propósito de un caso","authors":"I. Lasierra Lavilla ,&nbsp;M.N. Albani Pérez ,&nbsp;J. Peinado García ,&nbsp;J.P. Caballero Castro ,&nbsp;S. Plou Izquierdo","doi":"10.1016/j.semerg.2023.102180","DOIUrl":"10.1016/j.semerg.2023.102180","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139673604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"No one writes to the colonel","authors":"L. Posado-Domínguez,&nbsp;L. Figuero-Pérez,&nbsp;A. Olivares-Hernández,&nbsp;E. Fonseca-Sánchez","doi":"10.1016/j.semerg.2023.102173","DOIUrl":"https://doi.org/10.1016/j.semerg.2023.102173","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139654196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Gestión de incidencias interniveles. La experiencia de un distrito de atención primaria","authors":"A. Ortega Carpio ,&nbsp;J. Rioja Ulgar ,&nbsp;A. Mestraitua Vázquez ,&nbsp;Y. Arco Prados ,&nbsp;J. Córdoba Gómez ,&nbsp;F. Carmona Romero","doi":"10.1016/j.semerg.2023.102179","DOIUrl":"https://doi.org/10.1016/j.semerg.2023.102179","url":null,"abstract":"<div><h3>Aim</h3><p>Determine the prevalence and define the profile of interlevel incidences (ININ) between primary care (PC) and hospital (HC).</p></div><div><h3>Design</h3><p>Multicenter cross-sectional descriptive study.</p></div><div><h3>Site</h3><p>Primary care.</p></div><div><h3>Participants</h3><p>Professionals from a Health District and its reference hospitals.</p></div><div><h3>Interventions</h3><p>ININ are errors in communication between PC and HC professionals derived from administrative, pharmaceutical or clinical procedures not resolved during the formal interlevel communication processes, which requires a coordinated and validated response from the health care directions to not overload the family physician.</p></div><div><h3>Main measurements</h3><p>ININ by category, hospital services and health centers, total and validated, relative to the total number of referrals, and the reason for the ININ.</p></div><div><h3>Results</h3><p>We detected 2011 ININs (3.36%) among the 59.859 referrals, although only 1684 were validated (83.7%). Most were administrative (59.5%), followed by pharmaceutical (24.2%), clinical (10.2%) and reverse (6.1%). 41.3% of the clinical ININs were grouped around 5 hospital specialties, and 45.9% in 5 health centers. The main reasons for clinical ININ were non-prescription of the recommended pharmacological treatment in outpatient clinics or on hospital discharge (27.3%), request for referral to another hospital specialist (27.9%), or request to referral in person to patients who had already been referred by teleconsultation (17.8%).</p></div><div><h3>Conclusions</h3><p>3.36% of interlevel referrals are accompanied by incidents and 83.7% are validated and processed. It is necessary to develop ININ management tools to guarantee safe healthcare and debureaucratize PC.</p></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139652868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Immunogenicity of BNT162b2 vaccine after two and three doses: Correspondence","authors":"H. Daungsupawong ,&nbsp;V. Wiwanitkit","doi":"10.1016/j.semerg.2023.102132","DOIUrl":"https://doi.org/10.1016/j.semerg.2023.102132","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139654195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"El consumo de medicamentos como factor asociado al estado de fragilidad en personas mayores de 65 años en España","authors":"J.M. Ignacio Expósito ,&nbsp;N. Carrillo Peñas ,&nbsp;M. Rosety Rodríguez ,&nbsp;C. Lagares Franco","doi":"10.1016/j.semerg.2023.102177","DOIUrl":"10.1016/j.semerg.2023.102177","url":null,"abstract":"<div><h3>Introduction</h3><p>Frailty in the elderly is a concept in constant evolution, with a significant impact on the morbidity and mortality of patients. We assessed the associative strength of the Timed Up and Go test (TUG) and medication consumption in frailty and associated risk using various methods.</p></div><div><h3>Material and methods</h3><p>Observational, cross-sectional, multicenter study carried out in 128 Primary Care Centers distributed throughout Spain, has a total sample of 2422 patients over 65 years of age, estimating the prevalence of frailty with the TUG test. Descriptive analysis of the categorical variables and associative strength of TUG for frailty and medication consumption was performed with distribution of absolute and relative frequencies and multinomial logistic regression. SPSS 22.0 was used, considering statistical significance <em>p</em> <!-->=<!--> <!-->0.05.</p></div><div><h3>Results</h3><p>The prevalence of frailty in the sample was 13.7%, accepting as frailty those subjects who obtained a score &gt;20<!--> <!-->s in performing the TUG test. A third of these subjects classified as frail took more than 30<!--> <!-->s to complete the test and 32.5% of those studied would be classified as “pre-frail”.</p><p>We found a slight difference in the prevalence of frailty if we analyze the data according to sex, being 10.8% in men compared to 15.8% in women.</p><p>Regarding pharmacological consumption, 72.8% of the subjects consume 5 or more drugs daily with similar proportions by sex, and with an average consumption of 6.57 drugs.</p><p>The drugs with the greatest association with the degree of frailty were drugs used for dementia (40% of individuals who consumed them were considered frail), antiparkinsonian drugs (38%), antipsychotics (34%), antianemics (26.2%), anticoagulants (22.2%) and antiepileptics (21.1%).</p></div><div><h3>Conclusions</h3><p>The incidence of frailty in elderly patients in Spain is initially notable, being present in 13.7% through the application of the TUG test.</p><p>The age variable is the one that is most significantly associated with the frailty of the elderly patient.</p><p>An association was demonstrated between the degree of frailty and total medication consumption. The prevalence of frailty was 4.7% in the non-polypharmacy group compared to 15.4% in the polypharmacy group and reaching 23.4% in the extreme polypharmacy group.</p><p>The drugs with a greater association with the patient's degree of frailty were those used in the neurological/psychiatric sphere (antidementia, antiparkinsonian, antipsychotic or antiepileptic drugs).</p></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139652130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Tras la COVID-19 y las muchas epidemias estacionales de gripe, ¡qué poco hemos aprendido!","authors":"F. Rodríguez Artalejo","doi":"10.1016/j.semerg.2024.102196","DOIUrl":"10.1016/j.semerg.2024.102196","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139567689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Covid persistente y discapacidad","authors":"D. Suárez ,&nbsp;E. Pascual ,&nbsp;J.R. Soravilla","doi":"10.1016/j.semerg.2023.102189","DOIUrl":"10.1016/j.semerg.2023.102189","url":null,"abstract":"<div><p>Long covid is a health problem that will entail a high hidden cost attributable to the pandemic years after it because it affects the work capacity of many workers. Given the millions of covid-19 cases worldwide and current research showing that one in 7<!--> <!-->covid-19 patients remain symptomatic at 12 weeks, the number of long covid patients is likely to be substantial. Long covid is characterized by heterogeneous sequelae that often affect multiple systems, organs with an impact on the functioning and capacity of the worker. Workers with long covid symptoms can return to their occupation but this involves a complex individualized approach to the impact of symptoms on work, adjustments and modifications to the workplace. Patients with long covid typically report prolonged multisystem involvement and signicant disability. The psychological cost to the worker must also be addressed. A survey by the Community of Madrid (CCOO, SATSE, CSIF, AMYTS) in 2022 reveals that 24.5% of those affected by long covid were sick for more than 12 months; 30% of those affected by persistent covid need and adaption to their workplace. In Spain, more than 10<!--> <!-->million people infected with SARS-CoV-2 have been reported since the pandemic began, so it is estimated that there could be one million people with persistent covid. In 2021 alone there were more than 2.6 million sick leave due to covid-19 in Spain, the average duration of which was 10 days. One hundred million people around the world suffer from persistent covid, but few countries officially count them, nor do they help those affected with employment. In advanced countries, like the United States, long covid is treated as a disability,and the number of people with disabilities working or looking for work increased by 1.36 million, an increase of 23%, between January 2021 and January 2022. In the United Kingdom, some 200,000 people are not working or are not looking for work due to long-term health problems attributable to long covid, since the pandemic began.</p></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139567691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}